Centralised manufacture of Molecularly Targeted Radiation (MTR) Drugs for cancer treatment
Providing better access to life-changing treatments for cancer patients
PLEASE NOTE: IMCRC closed at the end of 2022 and this website is for reference purposes only.
Providing better access to life-changing treatments for cancer patients